Probiotics as Complementary Treatment for Metabolic Disorders

Area of Science:

• Microbiology
• Metabolic Health
• Gut Microbiome Research

Background:

• The gut microbiota significantly influences metabolic disorders like obesity and type 2 diabetes.
• Diet-induced dysbiosis promotes inflammation and metabolic endotoxemia, contributing to insulin resistance.

Purpose of the Study:

• To review the benefits of probiotics in managing metabolic disorders.
• To explore mechanisms by which probiotics restore gut barrier function and reduce metabolic endotoxemia.
• To discuss emerging strategies including novel bacterial strains and prebiotics.

Main Methods:

• Literature review of studies on probiotics, prebiotics, and gut microbiota.
• Analysis of mechanisms of action for various probiotic strains.
• Discussion of emerging therapeutic approaches like butyrate-producing bacteria, Akkermansia muciniphila, and genetically engineered bacteria.

Main Results:

• Widely used probiotics can decrease metabolic endotoxemia by restoring the intestinal mucosal barrier.
• Emerging strategies like butyrate-producing bacteria and Akkermansia muciniphila show promise.
• Prebiotics can enhance probiotic efficacy, and genetically engineered bacteria offer targeted anti-inflammatory delivery.

Conclusions:

• Probiotics offer a viable strategy to counteract diet-induced gut dysbiosis and associated metabolic disorders.
• Novel bacterial strains, prebiotics, and genetic engineering represent future directions for microbiome-based metabolic therapies.